Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-10-011012)

Filing Details

Accession Number:: 0001144204-10-011012
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-02 12:00:00
Reporting Period:: 2010-03-01

Filing Date:: 2010-03-02
Accepted Time:: 2010-03-02 16:22:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1318641	Cleveland Biolabs Inc	CBLI	Services-Commercial Physical & Biological Research (8731)	200077155

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1370084	Yakov Kogan	73 High Street Buffalo NY 14203	Coo, Secretary	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-01	2,500	$3.75	676,700	No	4	S	Direct
Common Stock	Disposition	2010-03-01	500	$3.90	676,200	No	4	S	Direct
Common Stock	Disposition	2010-03-01	1,700	$3.76	674,500	No	4	S	Direct
Common Stock	Disposition	2010-03-01	200	$3.82	674,300	No	4	S	Direct
Common Stock	Disposition	2010-03-01	200	$3.80	674,100	No	4	S	Direct
Common Stock	Disposition	2010-03-01	900	$3.78	673,200	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and represent approximately 0.8% of the reporting person's 715,200 shares held prior to adoption of the plan. The maximum sales subject to the plan in its entirety represent approximately 10.1% of the reporting person's shares held prior to adoption of the plan.